← Back to all trials
Not Yet Recruiting
NCT07248111
Effectiveness of the Mindful Compassion Care Program for Healthcare Professionals in Oncology and Palliative Care
Conditions: Professional Quality of Life, Palliative Care, Oncology
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 160
Sponsor: Azienda USL Reggio Emilia - IRCCS
Location: Azienda USL IRCCS di Reggio Emilia Reggio Emilia
Summary
This randomized controlled trial aims to evaluate the effectiveness of the Mindful Compassion Care Program (MCCP), a mindfulness- and compassion-based intervention designed to enhance the emotional and professional well-being of healthcare professionals (HPs). The study adopts a multi-center, open-label, randomized, parallel-group, superiority design and includes HPs (physicians, nurses, and nursing assistants) involved in the clinical care of cancer patients across different settings and disease phases. Eligible participants must not have attended MBSR or other mindfulness-/compassion-based interventions in the preceding six months.
The RCT has a primary objective of assessing the MCCP's effectiveness in increasing positive emotions and reducing negative emotions among HPs working in oncology and palliative care. Secondary objectives include evaluating improvements in professional quality of life and self-compassion. After providing informed consent, HPs will be randomized to receive either the MCCP (experimental group) or no intervention (control group).
Eligibility Criteria
Inclusion Criteria:
* Being a healthcare professional (physicians, nurses, or nursing assistants) involved in the clinical management of cancer patients across different care settings and illness phases.
* Age ≥ 18 years
Exclusion Criteria:
* HPs must not have attended MBSR or other mindfulness/compassion-based interventions, including in educational or clinical settings, involving activities similar to those in the present study in the previous six months.
Source: ClinicalTrials.gov (NCT07248111). StuddyBuddy aggregates publicly available trial information.